Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: Prevalence and impact on health

Inflammatory Bowel Diseases

Volumn 12, Issue 1, 2006, Pages 38-46

  Farrokhyar, Forough ^a   Marshall, John K ^a   Easterbrook, Brock ^a   Irvine, E Jan ^b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Functional gastrointestinal disorder; Health resources; IBD; Mood disorder; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENTERITIS; FEMALE; GASTROINTESTINAL DISEASE; HEALTH CARE UTILIZATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE;

ADULT; FEMALE; GASTROINTESTINAL DISEASES; HEALTH SERVICES; HUMANS; INFLAMMATORY BOWEL DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; MOOD DISORDERS; PREVALENCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; REGRESSION ANALYSIS; RISK FACTORS;

EID: 29744437704     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000195391.49762.89     Document Type: Article

References (46)

1. Thompson WG, Irvine EJ, Pare P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci. 2002;47:225-235.
2. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569-1580.
3. Minderhoud IM, Oldenburg B, Wismeijer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci. 2004;49:469-474.
4. Guthrie E, Jackson J, Shaffer J, et al. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn's disease. Am J Gastroenterol. 2002;97:1994-1999.
5. Simren M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol. 2002;97:389-396.
6. Coates MD, Mahoney CR, Linden DR, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 2004;126:1657-1664.
7. Magro F, Vieira-Coelho MA, Fraga S, et al. Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig Dis Sci. 2002;47:216-224.
8. Qian BF, El Salhy M, Melgar S, et al. Neuroendocrine changes in colon of mice with a disrupted IL-2 gene. Clin Exp Immunol. 2000;120:424-433.
9. Berman SM, Naliboff BD, Chang L, et al. Enhanced preattentive central nervous system reactivity in irritable bowel syndrome. Am J Gastroenterol. 2002;97:2791-2797.
10. El Salhy M, Danielsson A, Stenling R, et al. Colonic endocrine cells in inflammatory bowel disease. J Intern Med. 1997;242:413-419.
11. Lee OY, Mayer EA, Schmulson M, et al. Gender-related differences in IBS symptoms. Am J Gastroenterol. 2001;96:2184-2193.
12. Arutiunian MV, Akopian AA, Makarian AP, et al. [The biogenic amine level of patients with functional and inflammatory diseases of the large intestine] Soderzhanie biogennykh aminov u bol'nykh s funktsional'nymi i vospalitel'nymi zabolevaniiami tolstoi kishki. Vrach Delo. 1990;12:66-69.
13. Mulak A. Testing of visceral sensitivity. J Physiol Pharmacol. 2003;54(Suppl 4):55-72.
14. Szigethy E, Levy-Warren A, Whitton S, et al. Depressive symptoms and inflammatory bowel disease in children and adolescents: a cross-sectional study. J Pediatr Gastroenterol Nutr. 2004;39:395-403.
15. Lechin F, Vander DB, Lechin A, et al. Plasma neurotransmitters and cortisol in chronic illness: role of stress. J Med. 1994;25:181-192.
16. Chang L, Mayer EA, Johnson T, et al. Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain. 2000;84:297-307.
17. Beshay H, Pumariega AJ. Sertraline treatment of mood disorder associated with prednisone: a case report. J Child Adolesc Psychopharmacol. 1998;8:187-193.
18. Huerta I, Bonder A, Lopez L, et al. [Differences in the stress symptoms rating scale in Spanish between patients with irritable bowel syndrome (IBS) and healthy controls] Diferencias en la escala de gravedad de sintomas de estres en Español entre pacientes con sindrome de intestino irritable (SII) y controles sanos. Rev Gastroenterol Mex. 2002;67:161-165.
19. Collins SM, Barbara G, Vallance B. Stress, inflammation and the irritable bowel syndrome. Can J Gastroenterol. 1999;13:47A-49A.
20. Wells KB, Golding JM, Burnam MA. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry. 1988;145:976-981.
21. Walker EA, Gelfand MD, Gelfand AN, et al. The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease. Gen Hosp Psychiatry. 1996;18:220-229.
22. Sandler RS, Jordan MC, Kupper LL. Development of a Crohn's index for survey research. J Clin Epidemiol. 1988;41:451-458.
23. Simonis B, Heine M, Heene DL, et al. Evaluation and validation of a Crohn's disease inflammatory activity index reflecting pattern of endoscopic severity. Scand J Gastroenterol. 1998;33:283-288.
24. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut. 1999;45:II43-II47.
25. Drossman DA, Corazziari E, Talley NJ, et al. Research diagnostic questions for functional gastrointestinal disorders: Rome II Modular Questionnaire. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II: The Functional Gastointestinal Disorders. 2nd ed. McLean, Va: Degnon Associates; 2000:670-688.
26. Pezzone MA, Wald A. Functional bowel disorders in inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:347-357.
27. Konig HH, Ulshofer A, Gregor M, et al. Validation of the EuroQOL questionnaire in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002;14:1205-1215.
28. Irvine EJ. Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1999;28:S23-S27.
29. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol. 1996;91:1571-1578.
30. Pallis AG, Mouzas IA, Vlachonikolis IG. The inflammatory bowel disease questionnaire: a review of its national validation studies. Inflamm Bowel Dis. 2004;10:261-269.
31. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370.
32. Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut. 1987;28:1600-1604.
33. Isgar B, Harman M, Kaye MD, et al. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983;24:190-192.
34. Collins SM, Vallance B, Barbara G, et al. Putative inflammatory and immunological mechanisms in functional bowel disorders. Bailliere's Best Pract Res Clin Gastroenterol. 1999;13:429-436.
35. Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994;107:3-11.
36. Munkholm P, Langholz E, Davidsen M, et al. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol. 1995;30:699-706.
37. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002;16:51-60.
38. Halder SL, Locke GR III, Talley NJ, et al. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther. 2004;19:233-242.
39. Simren M, Abrahamsson H, Svedlund J, et al. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol. 2001;36:545-552.
40. Johnson JA, Pickard AS. Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. Med Care. 2000;38:115-121.
41. Mearin F, Roset M, Badia X, et al. Splitting irritable bowel syndrome: from original Rome to Rome II criteria. Am J Gastroenterol. 2004;99:122-130.
42. Levy RL, Von Korff M, Whitehead WE, et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol. 2001;96:3122-3129.
43. Maunder RG, Greenberg GR. Comparison of a disease activity index and patients' self-reported symptom severity in ulcerative colitis. Inflamm Bowel Dis. 2004;10:632-636.
44. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol. 2003;98:1578-1583.
45. Spiller R. Probiotics: an ideal anti-inflammatory treatment for IBS? Gastroenterology. 2005;128:783-785.
46. Spiller RC. Estimating the importance of infection in IBS. Am J Gastroenterol. 2003;98:238-241.